Volume 6,Issue 4
Discussion on the Value of Six-item Detection of Sex Hormones by Chemiluminescence Immunoassay in the Diagnosis and Treatment of Gynecological Endocrine Diseases
Objective: To explore the value of using chemiluminescence immunoassay to detect six sex hormones in the diagnosis and treatment of gynecological endocrine diseases, and to compare it with the indicators of healthy women. Methods: 50 patients with gynecological endocrine diseases admitted to our hospital from January 2022 to December 2023 were selected as the disease group, and 50 healthy women who underwent physical examinations in our hospital during the same period were selected as the healthy group. Chemiluminescence immunoassay was used to detect six sex hormones (follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, testosterone, and prolactin) in the two groups of research subjects, and the test results of the two groups were compared. Results: The levels of follicle-stimulating hormone, luteinizing hormone, testosterone and prolactin in the disease group were higher than those in the healthy group, while the levels of estradiol and progesterone were lower than those in the healthy group, and the differences were statistically significant (P < 0.05). Conclusion: The detection of six sex hormones by chemiluminescent immunoassay is of great value in the diagnosis and treatment of gynecological endocrine diseases. By comparing with the indicators of healthy women, it can provide a reliable basis for the diagnosis and treatment of diseases.
[1] Hou Q, 2025, Research on Process Optimization of Simultaneous Detection of Sex Hormones by Chemiluminescence Method. Laboratory Testing, 3(13): 57–59.
[2] Li X, Yan Y, Yu Q, 2024, Effects of Gengniangan Capsule Combined with Hormone Replacement Therapy on Sex Hormone Levels, Thyroid Hormones and Immune Function in Patients with Menopausal Syndrome. Chinese Journal of Gerontology, 44(06): 1388–1391.
[3] Zhang H, 2024, Clinical Value of CLIA Method for Detecting Six Sex Hormones in the Diagnosis of Female Reproductive Endocrine Diseases. Systems Medicine, 9(01): 153–156.
[4] Sun L, Liang X, Liang C, et al., 2023, Correlation between Sex Hormone Levels and Immune Regulation Imbalance in PCOS Infertile Patients and Its Predictive Value for Ovulation Outcome after Ovulation Induction Treatment. Chinese Sexual Science, 32(12): 68–72.
[5] Chen F, 2023, Expression and Correlation Analysis of miR-21/SIRT1 in Premature Ovarian Insufficiency. Chinese Maternal and Child Health Care, 38(17): 3269–3272.
[6] Xiong D, 2023, Diagnostic Analysis of Gynecological Diseases Using Chemiluminescence Instrument to Detect Six Items of Sex Hormones. China Medical Device Information, 29(06): 87–89.
[7] Deng Y, Huang M, Yu F, Jian C, 2022, Correlation between Sex Hormone Levels and Interleukin-6 in Patients with Postmenopausal Primary Sjögren’s Syndrome. Chinese Maternal and Child Health Care, 37(21): 3906–3909.
[8] Fan X, Zhu Z, Zhu H, et al., 2022, Correlation Analysis of Serum NO and ET Levels with Sex Hormone Levels and Sperm Quality in Patients with Varicocele. Chinese Experimental Diagnostics, 26(09): 1324–1327.
[9] Huang W, 2022, Application Value of Chemiluminescent Immunoassay of Serum Hormones in Male Sexual Dysfunction. Systems Medicine, 7(13): 87–90.
[10] Ge J, Yang N, Zhang X, et al., 2022, Comparative Analysis of Chemiluminescence Method and Liquid Chromatography Tandem Mass Spectrometry for the Determination of Sex Hormones in Women with Polycystic Ovary Syndrome. Zhongnan Pharmacy, 20(03): 561–564.